Engineered CAR-T cells block key protein to break solid tumors' immune shield

UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block their attack, and fuel tumor growth.

Continue Reading

News Source: medicalxpress.com